Log in or Sign up for Free to view tailored content for your specialty!
Biologics News
Study: PRP significantly improves midterm outcomes for jumper’s knee
Platelet-rich plasma was more effective than extracorporeal shock wave therapy in the treatment of athletes with jumper’s knee, according to researchers from Rome.
Study: BMP does not significantly affect nonunion rates in spinal fusion
Bone morphogenic protein did not statistically significantly reduce the rate of nonunion in spinal fusions, according to recently presented research.
Log in or Sign up for Free to view tailored content for your specialty!
Promising early results seen with biologic arthroplasty technique for knee lesions
SAN ANTONIO — Researchers discovered improved outcome scores at 3 years for patients with cartilage lesions of the knee who underwent mini arthrotomy and with bone marrow aspirate concentrate covered with a collagen I/III matrix.
Promising early results seen with biologic arthroplasty technique for knee lesions
SAN ANTONIO — Researchers discovered improved outcome scores at 3 years for patients with cartilage lesions of the knee who underwent mini arthrotomy and with bone marrow aspirate concentrate covered with a collagen I/III matrix.
Tanezumab reduced pain, increased function in patients with hip OA
Researchers found tanezumab was effective in treating patients with hip osteoarthritis compared to placebo, although they observed higher adverse event rates in the tanezumab group in a double-blind, placebo-controlled phase 3 trial that lasted 32 weeks.
Researchers get stem cells to differentiate into NP cells with hydrogel carrier
Investigators at the AO Research Institute, in Davos, Switzerland, showed that when bone marrow-derived mesenchymal stem cells were applied to an intervertebral disc the cell viability could be preserved and possibly enhanced by using a thermoreversible hyaluronan-based hydrogel carrier.
Mesenchymal stem cells yield promising results, multiple orthopaedic applications
Although research on the use of stem cells in orthopaedic surgery is still in its infancy, there are promising early results in cartilage repair, treating nonunions and osteoarthritis. Significant work remains, however, before they can be used routinely in patients.
Platelet-rich plasma promises pain relief and healing, but remains controversial
The use of platelet-rich plasma remains controversial as treatment regimens and formula concentrations are not standardized, high-level studies proving efficacy are few and many health care systems hesitate to adopt the treatment due to lack of reimbursement.
Wright Medical Group Inc. completes acquisition of BioMimetic Therapeutics
Wright Medical Group Inc. recently announced that it has completed its acquisition of BioMimetic Therapeutics Inc.
OsteoMed launches bone void and gap filler
OsteoMed LLC has announced its launch of OsteoVation Qwik, which is indicated to fill bony voids and gaps of the skeletal system.
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read
-
Headline News
‘Truly alarming’: Life expectancy gap in the US now up to 20 years
November 22, 20243 min read -
Headline News
Autoantibodies present in long COVID, but not a ‘smoking gun’ for new autoimmune disease
November 25, 20242 min read -
Headline News
Cardiovascular disease deaths rising among younger adults living in rural areas
November 15, 20243 min read